Question 1

What is Tenaya Therapeutics?

Accepted Answer

Tenaya Therapeutics is a Company.

Question 2

How often does Tenaya Therapeutics appear in global news?

Accepted Answer

Tracked across 1 news events drawn from 8 articles.

Question 3

When was Tenaya Therapeutics first tracked by Ergen?

Accepted Answer

First tracked on Jun 02, 2026.

Question 4

When was Tenaya Therapeutics last mentioned in news?

Accepted Answer

Last active on Jun 02, 2026.

Question 5

What is Tenaya Therapeutics's current news sentiment?

Accepted Answer

Aggregate sentiment score: 20 on a -100 to +100 scale (negative = critical coverage, positive = favorable coverage).

Question 6

How prominent is Tenaya Therapeutics in global news coverage?

Accepted Answer

Attention score of 4, derived from article volume and coverage intensity across 1 events.

Question 7

What is the most recent event involving Tenaya Therapeutics?

Accepted Answer

Tenaya Therapeutics to Report TN-201 Data (Jun 02, 2026, 8 articles).

Question 8

How did the "Tenaya Therapeutics to Report TN-201 Data" event impact Tenaya Therapeutics?

Accepted Answer

Tenaya Therapeutics is announcing new interim data from its MyPEAK-1 Phase 1b/2 trial for Tennessee State Route 201, which could significantly impact its stock price and future development of its gene therapy.

Question 9

How is this data collected?

Accepted Answer

Ergen aggregates thousands of global news sources and extracts structured events, entities, and relationships with sentiment and attention metrics. Pages are daily static snapshots from the platform's live database.